Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × FAPI-46 × 1 year × Clear all

Sponsor

Conditions

Stomach Neoplasms 3 Pancreatic Neoplasms 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Thyroid Neoplasms 2 Testicular Neoplasms 2 Sarcoma 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Neuroendocrine Tumors 2 Neoplasms 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Transitional Cell 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Brain Neoplasms 2 Adrenal Gland Neoplasms 2 Vaginal Neoplasms 1 Uterine Neoplasms 1 Thymus Neoplasms 1 Solitary Fibrous Tumors 1 Skin Neoplasms 1 Salivary Gland Neoplasms 1 Penile Neoplasms 1 Pancreatic Ductal Adenocarcinoma (PDAC) 1 Neoplasms, Unknown Primary 1 Hematologic Neoplasms 1 Colorectal Neoplasms 1

Interventions

Paclitaxel 12 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 liposomal doxorubicin 5 Nivolumab 5 mirvetuximab soravtansine 4 Topotecan 4 ribociclib 3 olaparib 3 Fulvestrant 3 Drug Therapy 3 rucaparib 2 pegfilgrastim 2 palbociclib 2 oregovomab 2 niraparib 2 fludarabine phosphate 2 fludarabine 2 Irinotecan 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Cyclophosphamide 2 Blood Specimen Collection 2 1-dodecylpyridoxal 2 trastuzumab deruxtecan 1 spartalizumab 1 sargramostim 1 sacituzumab govitecan 1 isoquercitrin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡